• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

YX-2-107

CAS No. 2417408-46-7

YX-2-107 ( —— )

产品货号. M36609 CAS No. 2417408-46-7

YX-2-107 是一种选择性降解 CDK6 的 PROTAC (IC50= 4.4 nM)。YX-2-107 在体外能有效抑制 RB 磷酸化和 FOXM1 表达,并抑制大鼠体内 Ph+ ALL 的发展。YX-2-107 可用于 Ph 染色体阳性 (Ph+) 急性淋巴细胞白血病 (ALL) 的研究。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥2920 有现货
5MG ¥4546 有现货
10MG ¥7243 有现货
25MG ¥12981 有现货
50MG ¥19472 有现货
100MG ¥25704 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    YX-2-107
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    YX-2-107 是一种选择性降解 CDK6 的 PROTAC (IC50= 4.4 nM)。YX-2-107 在体外能有效抑制 RB 磷酸化和 FOXM1 表达,并抑制大鼠体内 Ph+ ALL 的发展。YX-2-107 可用于 Ph 染色体阳性 (Ph+) 急性淋巴细胞白血病 (ALL) 的研究。
  • 产品描述
    YX-2-107 is a PROTAC (IC50= 4.4 nM) that selectively degrades CDK6. YX-2-107 effectively inhibits RB phosphorylation and FOXM1 expression in vitro and inhibits the development of Ph+ ALL in rats. YX-2-107 can be used in the study of Ph chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).
  • 体外实验
    YX-2-107 (2000 nM; 48 h) shows inhibition of S phase in Ph+ BV173 and SUP-B15 cells.YX-2-107 (0, 1.6, 8, 40, 200, 1000 nM;4 h) selectively degrades CDK6 in BV173 cells.YX-2-107 (2000 nM; 72 h) inhibits RB phosphorylation and FOXM1 expression in Ph+ BV173 and SUP-B15 cells.Cell Cycle Analysis Cell Line:Ph+ BV173 and SUP-B15 cells Concentration:2000 nM Incubation Time:48 h Result:Inhibited S-phase entry.Western Blot Analysis Cell Line:Ph+ BV173 and SUP-B15 cells Concentration:2000 nM Incubation Time:72 h Result:Inhibited the phosphorylation of RB and the expression of FOXM1.
  • 体内实验
    YX-2-107 (10 mg/kg; i.p.; single) shows a maximum concentration of 741 nM (150-fold greater than CDK6 degradation IC50), with clearance from the plasma after 4 hours.YX-2-107 (150 mg/kg; i.p.; single daily for 3 days) is pharmacologically active in suppressing Ph+ ALL proliferation in mice.Animal Model:NRG-SGM3 mice (Ph+ ALL xenografts model).Dosage:150 mg/kg Administration:Intraperitoneal injection; single daily for 3 days Result:Suppressed the percentage of primary Ph+ ALL S-phase cells, the expression of CDK4/6-regulated phospho-RB and, to a lesser degree, FOXM1, and induced the selective CDK6 degradation.Animal Model:C57BL/6j mice.Dosage:10 mg/kg Administration:Intraperitoneal injection.
  • 同义词
    ——
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    PROTACs | CDK
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    2417408-46-7
  • 分子量
    889.95
  • 分子式
    C45H51N11O9
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO 中的溶解度 : 100 mg/mL (112.37 mM; 超声助溶 )
  • SMILES
    O=C1NC(=O)C(N2C(=O)C=3C=CC=C(OCC(=O)NCCCCNCC(=O)N4CCN(C5=CN=C(C=C5)NC=6N=CC7=C(N6)N(C(=O)C(C(=O)C)=C7C)C8CCCC8)CC4)C3C2=O)CC1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. De Dominici M, et al. Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs. Blood. 2020 Apr 30;135(18):1560-1573.?
产品手册
关联产品
  • 1-(2-fluorophenyl)-3...

    1-(2-fluorophenyl)-3-[5-(2-methoxyphenyl)-1,3,4-thiadiazol-2-yl]urea is a chemical compound.

  • MFCD28987368

    MFCD28987368 是一种化合物。

  • Fz7-21 TFA

    Fz7-21 TFA ((Ac)-LPSDDLEFWCHVMY-NH2 TFA), a peptide antagonist of Frizzled 7 (FZD 7) receptors, selectively binds to FZD7 CRD subclass. The EC50 values are 58 and 34 nM for human and mouse FZD7 CRD, respectively.